Inventiva (IVA) Research & Development (2019 - 2021)
Inventiva's (IVA) quarterly Research & Development came in at -$14.3 million in Q2 2021, down 99.91% year-on-year from -$15.3 billion in Q2 2020, and down 65.27% quarter-over-quarter from -$8.7 million in Q1 2021.
Inventiva (IVA) Research & Development (2019 - 2021) Analysis & Trends
Inventiva's Research & Development history runs 3 years deep, the most recent figure standing at -$14.3 million for Q2 2021.
- On a quarterly basis, Research & Development fell 99.91% year-over-year to -$14.3 million in Q2 2021; TTM through Jun 2021 was -$58.5 million, a N/A change from a year earlier, with the FY2025 full-year figure at $101.3 million, up 4.33% from the prior year.
- Research & Development slipped to -$14.3 million in Q2 2021 per IVA's latest filing, from -$8.7 million in the prior quarter.
- Across five years, Research & Development topped out at -$6.7 million in Q1 2020 and bottomed at -$37.4 million in Q4 2019.
- The 3-year median for Research & Development is -$11.5 million (2021), against an average of -$17.1 million.
- Across the five-year window, Research & Development advanced 24.4% in 2020 and plunged 99.91% in 2021, its largest moves.
- Year by year, Research & Development stood at -$37.4 million in 2019, then advanced by 24.4% to -$28.3 million in 2020, then soared by 49.27% to -$14.3 million in 2021.
- Per Business Quant, the three latest IVA Research & Development figures stand at -$14.3 million (Q2 2021), -$8.7 million (Q1 2021), and -$28.3 million (Q4 2020).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -17.94 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 541.22 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -2.31 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 961.60 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 1.54 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 15.66 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1.37 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 343.97 Mn |
| 10 | Inventiva | 842.48 Mn | 842.48 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2021 | -14.35 Mn |
| Mar 31, 2021 | -8.68 Mn |
| Dec 31, 2020 | -28.28 Mn |
| Jun 30, 2020 | -7.18 Mn |
| Mar 31, 2020 | -6.69 Mn |
| Dec 31, 2019 | -37.40 Mn |